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Ras proteins must be localized to the inner surface of the plasma membrane to be biologically active. The
motifs that effect Ras plasma membrane targeting consist of a C-terminal CAAX motif plus a second signal
comprising palmitoylation of adjacent cysteine residues or the presence of a polybasic domain. In this study,
we examined how Ras proteins access the cell surface after processing of the CAAX motif is completed in the
endoplasmic reticulum (ER). We show that palmitoylated CAAX proteins, in addition to being localized at the
plasma membrane, are found throughout the exocytic pathway and accumulate in the Golgi region when cells
are incubated at 15°C. In contrast, polybasic CAAX proteins are found only at the cell surface and not in the
exocytic pathway. CAAX proteins which lack a second signal for plasma membrane targeting accumulate in the
ER and Golgi. Brefeldin A (BFA) significantly inhibits the plasma membrane accumulation of newly synthe-
sized, palmitoylated CAAX proteins without inhibiting their palmitoylation. BFA has no effect on the trafficking
of polybasic CAAX proteins. We conclude that H-ras and K-ras traffic to the cell surface through different
routes and that the polybasic domain is a sorting signal diverting K-Ras out of the classical exocytic pathway
proximal to the Golgi. Farnesylated Ras proteins that lack a polybasic domain reach the Golgi but require
palmitoylation in order to traffic further to the cell surface. These data also indicate that a Ras palmitoyl-
transferase is present in an early compartment of the exocytic pathway.
Ras proteins operate as molecular switches in diverse sig-
naling pathways that regulate cell growth and differentiation
(8, 26). However, in order to signal, Ras proteins must be
localized to the inner surface of the plasma membrane (58).
This requirement reflects the role that Ras plays in recruiting
cytosolic effectors to the cell surface, where they are, in turn,
either activated or juxtaposed with their own specific target
proteins. For example, the serine threonine kinase Raf-1 is
recruited to the plasma membrane by activated Ras (53),
where it is activated by interactions with membrane lipids,
tyrosine kinases, and possibly phosphatases (32, 37). Similarly,
the exchange factor RalGDS is relocalized to the plasma mem-
brane by activated Ras, positioning it in the same compartment
as the Ral GTPase, which it, in turn, activates (29, 57).
The membrane anchors used by the Ras proteins to attach to
the plasma membrane have been well characterized. All Ras
isoforms terminate in a CAAX motif that is sequentially far-
nesylated, AAX proteolyzed, and methylesterified (9, 15, 19).
The processed CAAX motif then operates with a second signal
in the adjacent hypervariable region to target Ras to the
plasma membrane. This second signal is cysteines 181 and 184
in H-ras, and cysteine 181 in N-ras, and these cysteines un-
dergo palmitoylation (19). In contrast, the second signal in
K-ras comprises multiple lysine residues (175 to 180), which
form a polybasic domain (20). These minimal C-terminal mo-
tifs, amino acids 181 to 189 in H-ras and 175 to 188 in K-ras,
are sufficient to target heterologous proteins to the plasma
membrane (2, 18, 19). Indeed, targeting of Raf-1 and phos-
phoinositol 3-kinase to the plasma membrane using these min-
imal motifs is sufficient to partially activate these Ras effectors
(30, 31, 49).
One consequence of each Ras isoform’s having a different
membrane anchor is that it may be directed to a different
microdomain within the plasma membrane. In direct support
of this concept, we have recently shown that the function of
H-ras, but not K-ras, is critically dependent on cholesterol-rich
microdomains, or lipid rafts, within the plasma membrane
(46). Lipid rafts have been proposed as important substruc-
tures of the plasma membrane which can operate as signaling
platforms (48), facilitating interactions between diverse signal-
ing proteins, including tyrosine kinases, Src family kinases,
G-protein subunits, and Ras (35, 39). The association of palmi-
toylated H-ras, but not polybasic K-ras, with such lipid rafts
(23, 46) may therefore explain biochemical, and hence biolog-
ical, differences between the various Ras proteins. For exam-
ple, Ras isoforms vary in the ability to activate Raf and phos-
phoinositol 3-kinase (16, 59), probably reflecting the different
concentrations of coactivators of these effectors in the H-, K-,
and N-Ras microdomains. In addition, RasGRF1 selectively
activates H-Ras (25) and RasGRP1 activates H-, N-, and K-ras
with various potencies (52), a likely consequence of differential
colocalization of these Ras exchange factors with their target
Ras isoforms at the plasma membrane. In turn, such biochem-
ical differences can be invoked to rationalize the differential
activation of specific Ras isoforms in human tumors (5) and
the selective requirement for K-ras, but not H- or N-ras, func-
tion in mouse embryogenesis (24, 56).
Intriguing questions invited by these observations are how
Ras proteins access the plasma membrane and, more specifi-
cally, how they become localized to their correct microdo-
mains. The first steps in this process must necessarily involve
the enzymes which modify the CAAX motif. First, farnesyl-
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transferase, a cytosolic enzyme (44), prenylates newly synthe-
sized Ras, generating a farnesylated CAAX sequence that is
the recognition sequence for the prenylcysteine endoprotease
which removes the AAX tripeptide (51). The mammalian pro-
tease hRce1 has recently been cloned (40) based on its se-
quence homology with the yeast RCE1 sequence (6). The
protease is membrane associated and proteolyzes geranylgera-
nylated and farnesylated CAAX motifs of all Ras, Ras-related,
and G-g subunits tested (28, 40). Moreover, a knockout of
Rce1 in mice is late embryonal stage lethal. Fibroblasts derived
from Rce12/2 mice show significant mislocalization of Ras
proteins to the cytosol (28), a consequence similar to that of
RCE1 disruption in yeast (6). After cleavage of the AAX
tripeptide, the now C-terminal farnesylated cysteine residue of
Ras is methylesterified by prenylcysteine carboxymethyltrans-
ferase (pcCMT), an endoplasmic reticulum (ER)-resident pro-
tein (12). The same pcCMT also methylates the C-terminal
geranylgeranylated cysteine residues of other Ras-related pro-
teins (11, 12). No knockout of pcCMT has been reported, but
disruption of the homologous STE14 protein in yeast has rel-
atively minor effects on RAS function and localization (21, 22).
In the Rab and Rho subfamilies of Ras-related proteins,
attachment to the correct cellular membrane involves guanine
nucleotide dissociation inhibitors (RhoGDI and RabGDI)
which extract the cognate GDP-bound prenylated proteins
from membranes into cytosolic complexes (13, 34, 55). These
soluble complexes allow delivery of the Ras-related protein to
the correct cellular membrane through the cytosol. Similarly,
Rab escort proteins also move geranylgeranylated Rab from
Rab geranylgeranyltransferase onto cell membranes (1). Since
no analogous GDI has been identified for Ras, we investigated
in this study whether Ras might access the plasma membrane
though a vesicular trafficking pathway. Moreover, given that H-
and K-ras operate in functionally distinct microdomains, we
examined whether they also traffic to the plasma membrane via
different routes.
MATERIALS AND METHODS
Plasmids. Expression plasmids for green fluorescent protein (GFP)-tH, GFP-
tK, and GFP-6QtK were constructed by ligating EcoRI/SalI cDNA fragments
from protein A expression plasmids, p381, pA-K, and pA-6Q, respectively (18,
19), into the cloning site of pEGFP-C1. GFP-tH therefore terminates with the
sequence CMSCKCVLS, GFP-tK ends with KKKKKKSKTKCVIM, and GFP-
6QtK ends with QQQQQQSKTKCVIM. pRSa-sialylT, the expression plasmid
for G-tagged sialyltransferase, has been described previously (43).
Cell culture and confocal microscopy. BHK cells were cultured at 37°C in
Dulbecco modified Eagle medium supplemented with 10% bovine calf serum.
Cells were plated onto coverslips at 60% confluence and transfected 4 h later,
using Lipofectamine (Life Technologies), with 1.6 mg of expression plasmid
pEGFP with or without an expression plasmid for G-tagged sialyltransferase.
After overnight incubation, cells were fixed with 4% paraformaldehyde, perme-
abilized in 0.2% Triton X-100, and blocked with 3% bovine serum albumin.
Sialyltransferase was visualized using 1:1,000 rabbit anti-G tag serum, and the
ER was stained using 1:120 rabbit anti-KDDD antibody (raised against the
sequence KDDDKDEL and specific for protein disulfide isomerase (PDI [kindly
provided by S. Fuller, EMBL]). Both primary antibodies were followed by 1:250
CY3-coupled anti-rabbit antibody (Zymed). Coverslips were mounted in mowiol.
Where indicated, cells were equilibrated at 15°C with medium supplemented
with 25 mM HEPES and incubated for 2 h with or without cycloheximide (50
mg/ml) at the same temperature. Fluorescence images were taken in a Bio-Rad
MRC-600 Zeiss microscope.
Cells to be incubated in brefeldin A (BFA) were returned to Dulbecco mod-
ified Eagle medium containing 10% serum 2 h after transfection and supple-
mented with BFA at 5 mg/ml or ethanol (carrier) at 5 ml/ml and incubated for a
further 5 h before fixation. For palmitic acid labeling, the medium was supple-
mented with 5 mM sodium pyruvate plus [3H]palmitic acid at 0.25 mCi/ml and
cells were incubated for only 3 h prior to harvesting to minimize breakdown of
the label. Lysates were prepared in ND buffer (50 mM Tris Cl [pH 7.6], 150 mM
NaCl, 1% Nonidet P-40, 0.5% deoxycholate plus protease inhibitors), 1 mg of
cleared lysate was immunoprecipitated with 4 mg of anti-GFP monoclonal anti-
serum (Boehringer Mannheim) coupled to protein G-agarose. After washing in
ND buffer, immunoprecipitates were resolved by sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis and fluorographed for 24 h at 270°C using es-
tablished protocols (19). Where indicated, taxol treatment (3 mM) was com-
menced 2 h prior to lipofection and continued until cells were fixed or harvested
12 h later. Tubulin was visualized using 1:500 anti-a-tubulin serum DM1a (Sig-
ma), followed by 1:400 CY3-coupled anti-mouse serum (Zymed).
Electron microscopy. Transfected BHK cells were fixed in 8% paraformalde-
hyde in 0.1 M phosphate buffer, pH 7.35, for 1 h at room temperature. They were
then washed with 0.2 M phosphate buffer, scraped from the culture dish, and
pelleted in a Microfuge. The cells were then resuspended in warm gelatin (10%
in phosphate buffer) and repelleted at maximum speed in the Microfuge. After
cooling, the gelatin-embedded cells were infiltrated with polyvinylpyrrolidone-
sucrose overnight at 4°C and then processed for frozen sectioning as previously
described (41). Ultrathin frozen sections (60 to 80 nm) were labeled, stained, and
viewed (JEOL 1010; Centre for Microscopy and Microanalysis) in accordance
with previously published techniques (41) with rabbit polyclonal antibodies to
GFP (kindly provided by David James, University of Queensland).
RESULTS
A polybasic domain excludes CAAX proteins from the exo-
cytic pathway. Recent work has shown that the mammalian
Ras methyltransferase is localized to the ER (12). Since meth-
ylesterification is the final CAAX modification, this suggests
that CAAX processing is completed on the cytoplasmic leaflet
of the ER membrane. To investigate how Ras proteins access
the plasma membrane from the ER, the complete targeting
signals of H- and K-ras, comprising the C-terminal 9 amino
acids of H-ras and the C-terminal 17 amino acids of K-ras,
were cloned onto the C terminus of GFP to give GFP-tH and
GFP-tK, respectively. Extensive previous work has shown that
all of the Ras membrane-targeting signals are contained within
these C-terminal sequences. We elected to use GFP-tH and
GFP-tK to investigate Ras trafficking because GFP is biologi-
cally inert and the role of the isolated targeting signals can
therefore be studied without the metabolism and architecture
of the cell being altered by the presence of overexpressed
biologically active Ras. The H- and K-ras motifs were com-
pared because although they share a CAAX motif, the critical
second signals within the motifs, palmitoylation in H-ras and a
polybasic domain in K-ras, are strikingly different.
First, we evaluated the extent to which GFP-tH and GFP-tK
are prenylated when expressed in BHK cells. This was assessed
using the Triton X-114 partitioning assay, which has been used
extensively to monitor the posttranslational processing of many
Ras and Ras-related proteins (15, 17). Wild-type GFP was
found to partition completely into the aqueous phase of Triton
X-114, indicating that it is highly hydrophilic (Fig. 1). In con-
FIG. 1. Prenylation of GFP-Ras constructs. BHK cells expressing GFP, GFP-
tH, or GFP-tK were lysed in Triton X-114. The lysates, normalized for protein
content, were warmed to 37°C, and the detergent (D) and aqueous (Aq) phases
were separated by centrifugation exactly as previously described (15, 17). Equal
proportions of each fraction were resolved by sodium dodecyl sulfate-polyacryl-
amide gel electrophoresis and immunoblotted using anti-GFP serum. Wild-type
GFP is hydrophilic and partitions exclusively into the aqueous phase, whereas
prenylation of the CAAX motifs of GFP-tH and GFP-tK imparts sufficient
hydrophobicity to partition the proteins into the detergent phase. Prenylation is
complete, since all of the expressed GFP-tH and GFP-tK has shifted into the
detergent phase.
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trast, both GFP-tH and GFP-tK partitioned exclusively into
the detergent phase of Triton X-114, indicating that all of the
expressed protein is hydrophobic. We therefore conclude that
GFP-tH and GFP-tK are fully prenylated when expressed in
BHK cells.
Next, we used confocal microscopy to compare the subcel-
lular distributions of GFP-tH and GFP-tK when they are ex-
pressed at equivalent levels in BHK cells. Figure 2A to C shows
that GFP-tK localized exclusively to the plasma membrane
with no significant labeling of intracellular structures. In con-
trast, while GFP-tH was also on the plasma membrane, a
substantial amount was present on perinuclear structures (Fig.
2D and E). Although there were no apparent differences be-
tween the two targeted GFPs in overall plasma membrane
distribution, membrane ruffles and projections were more ex-
tensively decorated with GFP-tK than with GFP-tH (Fig. 2C
and F). Cells were then examined using immunoelectron mi-
croscopy with antibodies to the GFP tag. In agreement with the
immunofluorescence analysis, GFP-tH and GFP-tK were both
readily detectable on the plasma membrane (Fig. 3A and B
and 4A). GFP-tH was also readily detectable on Golgi mem-
branes (Fig. 3A). In contrast, negligible GFP-tK labeling was
found on Golgi membranes even in cells with significant
plasma membrane staining (Fig. 4A). These differences were
not due to different expression levels of the respective proteins,
because quantitative immunoblotting of cell lysates showed
FIG. 2. Confocal localization of GFP-Ras constructs. BHK cells were transfected with GFP-tH, GFP-tK, or GFP-6QtK and incubated at 37°C for 18 h prior to
fixation for confocal microscopy. Scale bars, 10 mm. (A to F) Panels A, B, D, and E show cuts through cells at the level of the nucleus, whereas those in panels C and
F are higher-level cuts showing the cell surface. In cells expressing GFP-tK (A to C), the protein is almost completely localized to the plasma membrane. In cells
expressing GFP-tH (D to F), there is staining of the plasma membrane and intracellular structures. The intensity of plasma membrane fluorescence is less with GFP-tH
than with GFP-tK. (G to I) Representative cells expressing GFP-6QtK. There is substantial intracellular staining adjacent to and contiguous with the nuclear membrane,
with minimal staining of the plasma membrane. (J to L) Cells expressing GFP-6QtK were costained for PDI, an ER marker (red channel), with anti-KDDD antibody
(K and L). The overlay (L) shows extensive localization of GFP-6QtK to the ER. (M to O) GFP-6QtK was cotransfected with VSV G-tagged sialyltransferase, a
Golgi-resident protein, and the cells were stained for the G epitope tag. The overlay in panel O shows that GFP-6QtK is present in the Golgi, a result confirmed by
immunoelectron microscopy.
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FIG. 3. Ultrastructural localization of GFP-tH at 37 and 15°C. BHK cells were transfected with GFP-tH and incubated for 18 h at 37°C (A and B) or for 16 h at
37°C, followed by 2 h at 15°C (C and D). The cells were then labeled with antibodies to GFP, followed by 10-nm protein A-gold particles. Scale bars, 100 nm. (A and
B) Specific labeling for GFP-tH is evident on the plasma membrane (P). Despite the high expression level, there is negligible cytosolic labeling. Specific labeling is also
apparent on the Golgi complex (G). Putative endosomes (E) show low labeling, whereas small vesicles nearby show higher labeling (arrows). (C and D) At 15°C,
GFP-tH accumulates in groups of small vesicular structures (arrowheads) close to the Golgi complex (G), as shown at higher magnification in panel D. Again, note
the lack of significant cytosolic labeling and the absence of labeling on the ER surrounding the nucleus (N).
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FIG. 4. Ultrastructural localization of GFP-tK at 37 and 15°C. BHK cells were transfected with GFP-tK and incubated for 18 h at 37°C (A) or for 16 h at 37°C,
followed by 2 h at 15°C (B). The cells were then labeled with antibodies to GFP, followed by 10-nm protein A-gold particles. Scale bars, 100 nm. (A) Specific labeling
for GFP-tK is evident on the plasma membrane (P). Negligible labeling is apparent on the Golgi complex (G). (B) Again, specific labeling for GFP-tK is evident on
the plasma membrane (P). Negligible labeling is apparent on the Golgi complex (G), in contrast to the results obtained with GFP-tH (cf. Fig. 3C and D). N, nucleus.
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that the GFP constructs used in this study were expressed at
equivalent levels (Fig. 1).
We have shown previously that an isolated CVIM motif
(directing farnesylation) or CCIL motif (directing geranylgera-
nylation) does not target proteins to the cell surface (18).
However, whereas CVIM fusion proteins are largely soluble
upon cell fractionation, reflecting the relatively low affinity of
farnesylated proteins for membranes (47), CCIL fusion pro-
teins associate avidly with a P100 fraction that is not plasma
membrane (18). In the light of the recent data of Dai et al.
(12), we investigated whether, in intact cells, these mutant
incomplete targeting motifs result in mislocalization of Ras to
the ER or Golgi. The C-terminal sequence of K-ras-6Q, a
mutant protein in which all of the lysines in the polybasic
domain have been replaced with glutamine residues (20), was
cloned onto the C terminus of GFP to give GFP-6QtK. The
localization of GFP-6QtK, which therefore has a CVIM motif
but no second signal, was examined using confocal and immu-
noelectron microscopy. Figure 2G to I shows that very little
GFP-6QtK was present on the plasma membrane; rather, the
majority of the protein was concentrated adjacent to, or asso-
ciated with, the nuclear membrane. Costaining of cells with an
antibody (anti-KDDD) against the ER protein PDI showed
extensive colocalization with GFP-6QtK (Fig. 2J to L). GFP-
6QtK appeared more concentrated than the ER marker in the
perinuclear area of the cell, which corresponded to the posi-
tion of the Golgi complex as marked by vesicular stomatitis
virus (VSV) G epitope-tagged sialyltransferase (Fig. 2M to O).
Since GFP-6QtK, but not GFP-tK or GFP-tH, was detected on
ER membranes, we conclude that the second signal for plasma
membrane targeting is required to efficiently clear CAAX pro-
teins from the ER. In addition, since GFP-tH and GFP-6QtK,
but not GFP-tK, were clearly present on Golgi membranes, we
conclude that the polybasic domain functions as a sorting sig-
nal to exclude CAAX proteins from entering the Golgi.
Palmitoylated, but not polybasic, Ras proteins traffic though
the Golgi to the cell surface. The presence of GFP-tH on Golgi
membranes (Fig. 3) suggested that this palmitoylated protein
passes through the exocytic pathway. To investigate this in
more detail, BHK cells expressing GFP-tH and GFP-tK were
incubated at 15°C for 2 h before fixation for confocal or elec-
tron microscopy. This temperature block, which impairs trans-
port from the ER to the cis-Golgi (42), resulted in striking
increases in the amount of GFP-tH that was visible adjacent to
the nucleus (Fig. 5A) but caused no intracellular buildup of
GFP-tK (Fig. 5C). The intracellular accumulation of GFP-tH
was reversible and rapidly dissipated to control levels when the
cells were returned to 37°C (data not shown). Since the cells
were examined 18 h after transfection, a substantial amount of
GFP-tH has already been synthesized and trafficked to the cell
surface. To verify that the accumulation of GFP-tH at 15°C
consisted of newly synthesized and processed protein rather
than protein that may have recycled to the Golgi region from
the cell surface, the experiment was repeated after cells had
been preincubated with cycloheximide to block new protein
synthesis. Figure 5B shows that under these experimental con-
ditions, there was no intracellular accumulation of GFP-tH at
15°C. And consistent with this observation, there was no sig-
nificant colocalization of intracellular GFP-tH with Rab11, a
marker of the recycling endosome (54) (data not shown).
To identify the compartment in which GFP-tH was local-
ized, cells were cotransfected with sialyltransferase and stained
FIG. 5. Newly synthesized GFP-tH accumulates in the Golgi complex at 15°C. BHK cells were transfected with GFP-tH (A, B, and E to G) or GFP-tK (C and D)
or cotransfected with GFP-tH and VSV G-tagged sialyltransferase (E to G). After incubation at 37°C for 24 h, cells were incubated for a further 2 h at 15°C prior to
fixation. Scale bars, 10 mm. (A and B) GFP-tH accumulates in perinuclear structures after incubation at 15°C (A); this intracellular accumulation of GFP-tH is blocked
by incubation of the cells in cycloheximide for 2 h before and during the temperature block (B). (C and D) GFP-tK does not show any evidence of intracellular
accumulation at 15°C (C and D). Cells shown in panel D were incubated in cycloheximide. (E to G) All cells were incubated at 15°C prior to fixation. Sialyltransferase
(red channel), a Golgi marker, shows extensive colocalization with the intracellular accumulation of GFP-tH.
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with rabbit antiserum to the VSV G epitope (Fig. 5E to G).
The perinuclear accumulation of GFP-tH colocalized with sia-
lyltransferase, showing that this treatment caused the protein
to accumulate in the Golgi region (Fig. 5G).
Frozen sections of GFP-tH- and GFP-tK-expressing cells
were then examined by immunoelectron microscopy after in-
cubation at 15°C. Dense labeling for GFP-tH was observed on
tubulovesicular membranes in close proximity to the Golgi
complex (Fig. 3C and D). These tubulovesicular structures
represent an intermediate compartment of the exocytic path-
way between the ER and Golgi (33), and the accumulation of
GFP-tH in this compartment is therefore consistent with a
block in transport of GFP-tH from the ER to the Golgi. In
contrast, GFP-tK was readily detectable on the plasma mem-
brane of transfected cells incubated at 15°C but was not con-
centrated in the Golgi complex region, even in highly express-
ing cells (Fig. 4B). A quantitative electron microscopic analysis
of labeling associated with the plasma membrane and Golgi
apparatus of GFP-tH- and GFP-tK-expressing cells is pre-
sented in Fig. 6 and confirms the qualitative observations made
by immunofluorescence assay.
To extend these observations, we investigated whether an
intact Golgi is required to traffic GFP-tH or GFP-tK to the
plasma membrane. BHK cells were treated with BFA 2 h after
transfection, and plasma membrane staining was assessed by
confocal microscopy after a further 5 h of incubation. This
protocol was used to allow sufficient cells to express the trans-
fected protein to permit a quantitative analysis. Coverslips
were systematically examined, and the intensity of plasma
membrane staining of each cell encountered was graded from
strong (as in Fig. 2B or E) to weak or none (as in Fig. 2G to I).
Examples of cells from the BFA-treated cultures are shown in
Fig. 7A to D, and data from a representative experiment, in
which a total of .1,000 cells were counted, are presented in
Fig. 7E. Strikingly, the number of GFP-tH-expressing cells
with strong plasma membrane staining fell by 75% in the
presence of BFA compared with that of untreated control
cells, whereas the corresponding number of GFP-tK-express-
ing cells with strong plasma membrane staining was completely
unaffected (Fig. 7E). Moreover, greater than 50% of GFP-tH-
expressing cells treated with BFA showed strong perinuclear
staining (Fig. 7D), very similar to that shown in Fig. 2G to I.
Thus, BFA-induced disruption of the Golgi had no effect on
the delivery of GFP-tK to the plasma membrane but signifi-
cantly inhibited the plasma membrane access of GFP-tH.
To investigate whether BFA treatment inhibits the palmi-
toylation of GFP-tH, cells were metabolically labeled with
[3H]palmitic acid for 3 h in the presence of BFA and then
harvested. Lysates from BFA-treated and control, untreated
cultures were immunoprecipitated with anti-GFP serum and
analyzed by fluorography. Coverslips from the labeled culture
plates were also examined to quantify plasma membrane stain-
ing as described above. Figure 7F shows that incubation in
BFA had no effect on the incorporation of palmitic acid into
GFP-tH, even though the number of GFP-tH-expressing cells
with strong plasma membrane staining fell by 80% in the
BFA-treated culture. We conclude that access of newly syn-
thesized GFP-tH to palmitoyltransferase does not require an
intact Golgi. The simplest interpretation of these data is that
palmitoylation of GFP-tH occurs proximal to the Golgi in the
exocytic pathway and that the CAAX palmitoyltransferase is
therefore most likely in the ER.
Taxol perturbs the trafficking of polybasic Ras proteins. A
mechanistic insight into the nonexocytic pathway utilized by
K-ras comes from the work of Casey et al. (50), who reported
that K-ras binds with high affinity to taxol-stabilized microtu-
bules polymerized in vitro from monomeric tubulin. This bind-
ing of K-ras to microtubules is prenyl dependent and is not
seen with any other Ras or Ras-related protein. Moreover,
taxol treatment of intact cells results in mislocalization of
newly synthesized K-ras but has no effect on the localization of
H-ras (50). We therefore sought to extend these observa-
tions by examining the trafficking of GFP-tK and GFP-tH in
taxol-treated cells. Consistent with the previous report, taxol
treatment had no detectable effect on the plasma membrane
localization of newly synthesized GFP-tH (not shown) but
significantly reduced the plasma membrane localization of
GFP-tK (Fig. 8D and G). Importantly, subcellular fraction-
ation of BHK cells revealed that all of the GFP-tK remained
associated with the P100 membrane fraction in taxol-treated
cells (Fig. 8). Confocal sections of cells taken at the level of the
nucleus show that while some GFP-tK in taxol-treated cells is
localized at the plasma membrane, much is found in irregular
structures which do not show an ER- or Golgi-like staining
pattern (Fig. 8D and G). Some of these GFP-tK-decorated
structures have a tubular-vesicular appearance (Fig. 8D and
G). To examine the relationship between GFP-tK and the
microtubule network, cells expressing GFP-tK were costained
for tubulin. The thickening and reorganization of microtubules
induced by taxol are clearly visible when the untreated cells in
Fig. 8B are compared with the treated cells in Fig. 8E and H.
FIG. 6. Semiquantitative comparison of the subcellular distribution of GFP-
ras constructs. Cells expressing GFP-tK and GFP-tH were fixed after a 2-h
incubation at 15°C, cryosectioned, and examined by electron microscopy after
immunogold labeling for GFP. Cells positively expressing GFPtH or GFPtK
were assayed for the number of gold particles present on randomly chosen
fixed-unit lengths of plasma membrane (P.M) or in fixed-unit Golgi complex
areas (G.A). These data are, in part, arrayed as two scatter diagrams; note the log
difference in the y axis scales. The plasma membrane pool, which represents the
largest subcellular pool of Ras, contains similar amounts of labeling for GFPtH
and GFPtK, indicating that levels of expression were comparable for the two
peptides (means, 13.75 and 13.21 gold particles/mm, respectively). GFP-tH was
present on and in the vicinity of the Golgi apparatus (mean, 28.62 gold particles/
mm2), whereas GFPtK was almost completely excluded from this region (mean,
0.25 gold particles/mm2).
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The overlays of these confocal images show that there is very
little colocalization of intracellular GFP-tK and tubulin in the
taxol-treated cells (Fig. 8F and I), although some alignment of
the tubular-vesicular GFP-tK structures alongside microtu-
bules is evident in some cells (Fig. 8I). Electron microscopic
analysis (Fig. 9) supported these observations. Taxol-treated
cells showed abundant microtubule bundles which had negli-
gible labeling for GFP-tK. Labeling was observed on the
plasma membrane and within large multivesicular endosomes,
which were abundant in the taxol-treated cells (Fig. 9). Similar
multivesicular endosome carrier vesicles have been shown to
accumulate in nocodazole-treated BHK cells (14). In sum-
mary, these data show that GFP-tK does not directly associate
with microtubules in vivo but that taxol treatment results in
redistribution of GFP-tK away from the plasma membrane
into an endosomal compartment.
DISCUSSION
The experiments described in this paper address the intrigu-
ing question of how Ras proteins that have been posttransla-
tionally modified on the cytosolic leaflet of the ER membrane
FIG. 7. BFA inhibits the plasma membrane accumulation of GFP-tH but not GFP-tK. BHK cells were transfected with GFP-tH or GFP-tK. At 2 h after
transfection, BFA (5 mg/ml) was added to half of the cultures. After 5 h, coverslips were examined by confocal microscopy. Bar, 10 mm. (A to D) Representative cells
from control cultures (A and C) and BFA-treated cultures (B and D). The localization of GFP-tK (A and B) is unaffected, while GFP-tH (C and D) is prevented from
trafficking to the plasma membrane. (E) Greater than 450 cells (462 to 524) per experimental condition were scored for intensity of plasma membrane fluorescence
by an observer blind to the transfection and treatment conditions. The graph shows the percentages cells with clear plasma membrane staining. It is a representative
experiment that was repeated three times with similar results. CON, control. (F) BHK cells plated in 10-cm-diameter dishes were transfected with GFP-tH. At 2 h after
transfection, cells were switched to labeling medium containing [3H]palmitic acid; simultaneously, BFA (10 mg/ml) was added to half of the cultures (1BFA) and
ethanol carrier was added to the remainder (2BFA). After a further 3 h of incubation, coverslips were quantified as for panel E; the remainder of the cells were
harvested into lysis buffer. Lysates were immunoblotted (IB, lanes 1 and 2) or immunoprecipitated (IP, lanes 3 to 6) using monoclonal anti-GFP serum. Radiolabeled
proteins in the immunoprecipitates were visualized by fluorography (lanes 3 and 4). Immunoprecipitates were also probed with polyclonal anti-GFP serum to confirm
that equal amounts of GFP-tH had been captured (lanes 5 and 6). Note that there is no effect of BFA on GFP-tH expression (lanes 1 and 2) or on palmitic acid
incorporation (lanes 3 and 4). BFA did, however, decrease the number of cells with strong plasma membrane staining to 8% from the 48% in the untreated control.
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FIG. 8. Taxol causes redistribution of GFP-tK. BHK cells were incubated in taxol for 2 h prior to and 12 h after lipofection and then harvested for subcellular
fractionation or fixed for confocal or electron microscopy. The cytosolic (S 5 S100) and membrane (P 5 P100) fractions were prepared from cells expressing GFP-tK
as previously described (45), normalized for protein content, and immunoblotted with anti-GFP serum (upper panel). GFP-tK remained fully associated with the P100
fraction in taxol-treated cells. The lower panel shows confocal images of BHK cells from identical cultures that have been costained for a-tubulin. Cells in panels A
to F have been cut at the level of the nucleus. The images in panels G to I show the edge of a cell magnified 2.53 relative to the other images. Bar, 10 mm for panels
A to F and 4 mm for panels G to I. (A to C) Untreated control cells showing normal microtubules (red channel) and plasma membrane-localized GFP-tK (green
channel). (D to I) Taxol-treated cells show some thickening and disruption of the microtubules, accompanied by accumulation of intracellular GFP-tK and a reduction
in the amount of GFP-tK seen at the plasma membrane. GFP-tK is seen decorating vesicular and tubulovesicular structures, but there is very little actual colocalization
of GFP-tK with tubulin. Some of the tubulovesicular structures are apparently aligned alongside microtubules; this is seen particularly well in panels G to I.
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gain access to the inner surface of the plasma membrane. The
results presented here are fully consistent with the recent ob-
servations of Choy et al. (10), who examined in detail the
cellular trafficking of full-length N- and K-Ras proteins cou-
pled to GFP. Here we have focused on the ability of the
isolated H- and K-Ras membrane-targeting motifs to traffic
GFP to the plasma membrane and have made similar obser-
vations. Importantly, when taken together, the two studies
show that the C-terminal Ras motifs contain all of the relevant
signals for successful Ras trafficking. Moreover, they demon-
strate that the palmitoylated Ras proteins H- and N-ras use the
same trafficking pathway.
We found that proteins which have an intact second signal
for plasma membrane localization, palmitoylation or a polyba-
sic domain, are efficiently cleared from the ER, whereas pro-
teins which lack a second signal accumulate in the ER and
Golgi complex. This led to the important conclusion that pal-
mitoylation or a polybasic domain is an essential part of the
trafficking signal for Ras proteins. Moreover, a particularly
fascinating finding of the present study is the observation that
palmitoylated H-ras, but not K-ras, traffics to the plasma mem-
brane along the secretory pathway via the Golgi complex. This
gives new insights into the manner in which these two proteins,
which differ in membrane anchoring, reach their site of action
at the plasma membrane. We envisage a scheme in which the
H-ras and K-ras polypeptides are synthesized on cytosolic ri-
bosomes and farnesylated in the cytoplasm. The proteins then
associate with the ER for removal of the AAX tripeptide and
methylation of the C-terminal cysteine. The two isoforms are
then differently routed (Fig. 10). If a polybasic domain is
present, as in K-ras, the protein does not enter the conven-
tional exocytic pathway. This follows because no GFP-tK was
detectable in or near the Golgi at 37 or 15°C by either immu-
nofluorescence assay or electron microscopy. These data there-
fore suggest that the combination of a CAAX motif and a
polybasic domain comprises a sorting signal that directs K-ras
directly to the cell surface, bypassing the Golgi.
It is unclear exactly how K-ras accesses the plasma mem-
brane, although several mechanisms are possible. For example,
smgGDS, a weak exchange factor for K-ras, could operate as a
chaperone protein because it has been shown to extract K-ras
from cell membranes (27), in a fashion analogous to that of the
GDIs of Rho and Rab proteins, yet does not interact with H-
or N-ras. Alternatively, since farnesylated K-ras has a lower
affinity for membranes than palmitoylated H-ras, it is possible
that this lower avidity of membrane binding allows K-ras to
dissociate from the ER and bind directly to the plasma mem-
brane; although this seems less likely because GFP-6QtK,
which has no polybasic domain and hence has even lower
affinity for membranes than GFP-tK, remained associated with
the ER and Golgi membranes in intact cells. The complete
absence of GFP-tK from the ER is more consistent with an
active removal mechanism than a passive, equilibrium-driven
diffusion process.
Neither of these potential trafficking mechanisms can ac-
count for the intriguing observations that taxol treatment sig-
nificantly reduces the plasma membrane accumulation of
newly synthesized K-ras. This result strongly suggests that a
FIG. 9. Electron microscopic analysis of taxol-treated cells. BHK cells were
taxol treated and transfected as described in the legend to Fig. 8. Frozen sections
were then labeled with antibodies to GFP, followed by protein A-gold particles.
Specific labeling is associated with the plasma membrane and endosomal struc-
tures (arrows), but negligible labeling is associated with microtubules (small
arrows, bottom panel). N, nucleus; M, mitochondria; bars, 200 nm.
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functional microtubule network is necessary for K-ras to transit
the cell. We show here, however, that there is no obvious
colocalization of GFP-tK with tubulin in taxol-treated cells, as
might have been predicted from the study of Casey et al. (50).
Rather, we found that GFP-tK accumulates in intracellular
multivesicular and univesicular endosomal structures that are
only infrequently arrayed alongside taxol-stabilized microtu-
bules. There are two possible interpretations of these findings.
First, GFP-tK traffics from the ER to the plasma membrane
using microtubule-dependent vesicular transport and taxol
treatment results in a build up of GFP-tK in transport vesicles.
An important caveat is that K-ras must traffic to the plasma
membrane very quickly, because the GFP-tK taxol-sensitive
compartment was not visible in untreated cells. In this context,
it is worth noting that kinetic analysis does suggest that newly
synthesized K-ras accesses the cell surface more rapidly than
does N-ras (10). A second interpretation is that forward trans-
port of GFP-tK from the ER to the plasma membrane is
unaffected by taxol but that maintenance of the plasma mem-
brane pool requires functioning microtubules. In this case, in
taxol-poisoned cells, some of the plasma membrane-localized
GFP-tK enters and accumulates in a bulk flow endosomal
compartment, possibly due to disruption of early-to-late endo-
somal transport (14). Both interpretations have important yet
clearly different implications for the potential clinical manip-
ulation of K-ras plasma membrane association.
In the absence of a polybasic domain, CAAX proteins are
delivered to the Golgi complex and, if palmitoylated, are traf-
ficked to the plasma membrane (Fig. 10). Since palmitoylated
GFP-tH was cleared from the ER much more efficiently than
nonpalmitoylated GFP-6QtK, it is most likely that the Ras
palmitoyltransferase, like the pcCMT, is present in the ER.
This conclusion is supported by the observation that disruption
of the Golgi by BFA did not inhibit GFP-tH palmitoylation but
dramatically reduced GFP-tH trafficking to the plasma mem-
brane. Since some GFP-6QtK was detected in the Golgi, pal-
mitoylation cannot be absolutely required for ER-to-Golgi
transport but palmitoylation and an intact Golgi are clearly
essential for trafficking of H-ras from the ER through the
Golgi to the plasma membrane. The role of palmitoylation may
simply be to allow a more stable membrane association of
H-ras, which is required for further transport to the plasma
membrane. However, it is also possible that the requirement
for palmitoylation to escape from the Golgi indicates that the
palmitoyl group is required for sorting of H-ras into specific
carrier vesicles exiting the Golgi. These roles are not mutually
exclusive. Either way, H-ras behaves like a membrane protein,
being transported to the cell surface via the Golgi complex
while associated with the cytoplasmic face of the transported
membrane. H-ras is therefore a cytoplasmic cargo protein of
the exocytic pathway, and its delivery to the plasma membrane
is reliant on membrane traffic. Interestingly, a recent study
reached similar conclusions with respect to Lck, proposing
palmitoylation early in the exocytic pathway and vesicular
transport to the cell surface through the Golgi (3).
There appear to be two outcomes for CAAX proteins with
an incomplete trafficking signal: farnesylated Ras proteins with
relatively low affinity for membranes probably have a high rate
of dissociation from the ER and Golgi, which is why they are
recovered predominantly in the cytosol on cell fractionation
(19). In contrast, geranylgeranylated Ras proteins with an in-
complete trafficking signal have a higher affinity for mem-
branes (47) and remain associated with the ER. Similarly, Ras
proteins engineered to be N terminally myristoylated and C
FIG. 10. Model of Ras trafficking. After the common processing steps of farnesylation, AAX proteolysis, and methylation which are completed on the cytosolic
surface of the ER, the trafficking routes of the different Ras proteins diverge. K-ras, by virtue of its C-terminal polybasic domain, is sorted out of the conventional
exocytic pathway and takes an undefined pathway to the cell surface that bypasses the Golgi. H- and N-ras are palmitoylated by an ER-localized palmitoyltransferase
and enter the exocytic pathway; they traffic to the cell surface via the Golgi. OMe, carboxymethyl; PalmCoA, palmitoyl coenzyme A; SAM, S-adenosyl methionine;
PalmTase, palmitoyltransferase; MethTase, methyltransferase; FPTase, farnesyl protein transferase; Farnesyl-PP, farnesyl pyrophosphate.
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terminally farnesylated, but which lack a polybasic domain or
palmitoylation sites, fail to localize to the cell surface and
extensively decorate the nuclear membrane (7), implying that
these dually lipidated Ras proteins, with a high affinity for
membranes and no second signal, cannot exit and remain
bound to the ER. Other studies also emphasize the importance
of the second signal for plasma membrane targeting. N-termi-
nally myristoylated Ras proteins lacking a CAAX motif but
with an intact polybasic domain or palmitoylation sites localize
predominantly to the plasma membrane. Thus, the second
signal specifies targeting to the plasma membrane if the Ras
protein has a hydrophobic N or C terminus. Even more strik-
ingly, in the case of H-Ras, additional hydrophobicity other
than that provided by the acyl chain is also unnecessary for
plasma membrane binding: H-ras proteins with a C-terminal
polybasic extension in place of the CAAX motif undergo pal-
mitoylation, localize to the plasma membrane, and have bio-
logical activity (4, 36).
Finally, different trafficking mechanisms for the Ras iso-
forms can be rationalized in the light of recent data showing
that H-ras, but not K-ras, functionally associates with choles-
terol-rich surface domains (46). An attractive hypothesis is that
these lipid rafts, which can ultimately coalesce into caveolae in
the presence of caveolin, are assembled in the trans-Golgi
network and that H-ras needs to associate with the rafts at this
stage. In contrast, K-ras, which does not show reliance on
cholesterol-enriched domains for Raf activation, might show a
more random distribution over the cell surface (38) and there-
fore does not need such a specific trafficking pathway.
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